Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Dawapril versus Ena-denk enalapril tablets
PACTR202607847734586Not yet recruiting
- Sponsor
- Kenya Medical Research Institute
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of enalapril in hypertension (HTN) and heart failure (HF) (2 arms), sponsored by Kenya Medical Research Institute. Primary endpoints: Maximum plasma concentration (Cmax) of enalapril, Maximum plasma concentration (Cmax) of enalaprilat and 4 more. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
enalapril
03
Conditions
hypertension (HTN)heart failure (HF)
Beyond the preview
Go deeper on PACTR202607847734586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202607847734586.